- Home
- ELP vs ADMA Comparison
ELP vs ADMA Comparison
Compare ELP & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELP
- ADMA
- Stock Information
- Founded
- ELP 1954
- ADMA 2004
- Country
- ELP Brazil
- ADMA United States
- Employees
- ELP N/A
- ADMA N/A
- Industry
- ELP Electric Utilities: Central
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ELP Utilities
- ADMA Health Care
- Exchange
- ELP Nasdaq
- ADMA Nasdaq
- Market Cap
- ELP 5.5B
- ADMA 5.1B
- IPO Year
- ELP 1997
- ADMA N/A
- Fundamental
- Price
- ELP $9.14
- ADMA $18.56
- Analyst Decision
- ELP
- ADMA Strong Buy
- Analyst Count
- ELP 0
- ADMA 4
- Target Price
- ELP N/A
- ADMA $24.25
- AVG Volume (30 Days)
- ELP 279.7K
- ADMA 3.3M
- Earning Date
- ELP 08-06-2025
- ADMA 08-07-2025
- Dividend Yield
- ELP 4.86%
- ADMA N/A
- EPS Growth
- ELP 31.95
- ADMA N/A
- EPS
- ELP 0.17
- ADMA 0.84
- Revenue
- ELP $4,033,509,015.00
- ADMA $459,381,000.00
- Revenue This Year
- ELP N/A
- ADMA $23.35
- Revenue Next Year
- ELP $5.55
- ADMA $27.67
- P/E Ratio
- ELP $12.55
- ADMA $21.75
- Revenue Growth
- ELP 6.92
- ADMA 62.23
- 52 Week Low
- ELP $5.72
- ADMA $10.21
- 52 Week High
- ELP $9.28
- ADMA $25.67
- Technical
- Relative Strength Index (RSI)
- ELP 57.96
- ADMA 40.52
- Support Level
- ELP $8.86
- ADMA $17.35
- Resistance Level
- ELP $9.06
- ADMA $18.15
- Average True Range (ATR)
- ELP 0.16
- ADMA 0.87
- MACD
- ELP -0.03
- ADMA -0.25
- Stochastic Oscillator
- ELP 72.12
- ADMA 20.92
About ELP Companhia Paranaense de Energia (COPEL) (each representing one Unit consisting one Common Share and four non-voting Class B Preferred Shares)
Cia Paranaense De Energia Copel is engaged in the areas of generation, transmission, commercialization and distribution of energy. It operates a comprehensive and effective electrical system with its own generating plants, transmission lines, substations, electrical lines and grids of the distribution system. The company's reportable segments include Power generation and transmission, Power distribution, GAS, Power sale, Holding and Services. Majority of its revenue is generated from the Power generation and transmission segment under which it produces electricity from hydraulic, wind, and thermal projects and provides services of transmission and transformation of electric power and other related services.
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.